Patient Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.1M Sell
16,268,741
-1,103,560
-6% -$1.57M 1.04% 32
2025
Q1
$25.9M Sell
17,372,301
-508,945
-3% -$758K 1.33% 30
2024
Q4
$20M Sell
17,881,246
-56,448
-0.3% -$63.2K 0.92% 32
2024
Q3
$17M Sell
17,937,694
-236,964
-1% -$224K 0.83% 34
2024
Q2
$28.7M Buy
18,174,658
+721,203
+4% +$1.14M 1.53% 28
2024
Q1
$25.3M Buy
17,453,455
+1,469,755
+9% +$2.13M 1.23% 34
2023
Q4
$21.4M Buy
15,983,700
+2,230,524
+16% +$2.99M 1.13% 32
2023
Q3
$19.5M Buy
13,753,176
+2,509,616
+22% +$3.56M 1.15% 34
2023
Q2
$12.9M Buy
11,243,560
+9,779,800
+668% +$11.2M 0.72% 33
2023
Q1
$1.55M Buy
1,463,760
+665,560
+83% +$705K 0.69% 37
2022
Q4
$1.21M Buy
798,200
+500,000
+168% +$760K 0.59% 38
2022
Q3
$632K Hold
298,200
0.32% 40
2022
Q2
$400K Hold
298,200
0.18% 40
2022
Q1
$629K Hold
298,200
0.21% 42
2021
Q4
$1.11M Buy
+298,200
New +$1.11M 0.32% 38